Iron is bound to transferrin in the plasma. A specific receptor on the cell surface binds transferrin and internalizes transferrin and the iron in clathrin-coated pits. These invaginate to form vesicles which release iron to the cytoplasm. Inorganic iron can be transported by an alternative pathway from iron citrate, utilizing a cell surface integrin and a cytoplasmic protein mobilferrin. This article shows that the two pathways donate iron to mobilferrin which acts as an intermediate between the iron bound to transferrin and the incorporation of iron into hemoglobin. Mobilferrin is found associated with the transferrin containing vesicles, and becomes labeled with iron released from transferrin in the vesicles. Mobilferrin is also found in the cytoplasm where pulse-chase experiments show that it, in turn, releases iron to be used for the synthesis of hemoglobin. ( J. Clin. Invest.
Introduction
Iron is transported into mammalian cells via two described pathways. Most plasma iron is transported to cells in the body bound to transferrin. Cell membranes possess a transferrin receptor that binds the transferrin and invaginates into the cell to form a vesicle (1, 2) . Acidification of the contents of the vesicle releases iron from transferrin so that it is delivered to the cytoplasm. The vesicle then returns to the surface of the cell to deliver apotransferrin to the plasma (3, 4) .
A second pathway was sought in small intestinal absorptive cells because there are no transferrin receptors in microvilli (5) . This pathway absorbs soluble iron chelates, such as ferric citrate. The iron associates with a cell surface integrin (6, 7) and subsequently is transferred to a cytosolic protein named mobilferrin (8) .
Many investigators have reported that there is an alternative pathway for iron uptake in nonintestinal cells (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . Recently, it was shown in K562 and Raji cells that this pathway utilizes integrin and mobilferrin similar to intestinal cells (21) . Further, chase experiments in K562 erythroleukemia cells suggested there might be an interrelationship between the two pathways because some radioiron presented to the cells bound to transferrin was isolated from the cytosol complexed to mobilferrin (21) .
This study explores the postulated interrelationship between the transferrin-transferrin receptor pathway and the mobilferrin-integrin pathway (MIP). 1 Utilizing pulse chase experiments and Western blot analysis of membrane fractions isolated from K562 cells, sequential labeling of mobilferrin and hemoglobin was demonstrated in cells in which iron was transported to the cytosol bound to transferrin. Further, a close association of mobilferrin and transferrin containing vesicles was demonstrated in the cytosol of K562 cells. These findings suggested that mobilferrin is a component of both pathways.
Methods
Separation of membrane components. K562 cells were selected for these studies because they possess both the transferrin-transferrin receptor and the MIP pathway to transport iron into the cell (21) . Further, they synthesize hemoglobin at a slow rate which permitted identification of intermediate carriers of iron in pulse chase experiments when radioiron with a high specific activity (20 mCi/mg Fe) was utilized. Human apotransferrin (Sigma Chemical Co., St. Louis, MO) was labeled with 2 mol of 59 Fe-NTA (Dupont, Irving, TX) per mole of transferrin. Excess radioiron was removed by filtration (Centricon-10, Amicon, Danver, MA). K562 cells were grown in RPMI 1640 (GIBCO, Gaithersburg, MD) with 10% FCS in spinner flasks and collected by centrifugation. The cells were washed with 10 mM Hepes, 0.15 M NaC1, 0.1% glucose (HSG). The cell number was determined with a hemocytometer and viability was determined by Trypan blue exclusion. An aliquot of cells ( 12.5 ϫ 10 7 cells) was incubated with 0.25 mg of transferrin in 25 ml of HSG at 4 Њ C for 30 min. This allowed the transferrin to saturate the receptor (22) (23) (24) . The cells were rapidly warmed to 37 Њ C for the indicated time. Then the cells were chilled, collected by centrifugation, washed with HSG at 4 Њ C and resuspended in 2 ml of 10 mM Hepes pH 7.5 with 10 mM NaC1 (HNa) and sonicated with 25 W at 4 Њ C for 30 s. The solution was examined microscopically to insure complete cellular rupture had occurred and the suspension was applied to a 60-20% (W/W) linear sucrose gradient (24) in 36 ml polyallomer tubes. Centrifugation was performed in a Sorvall S28 centrifuge with a SS28/36 swingingbucket rotor at 19,000 rpm for 18 h. The tubes were punctured at the base and 1-ml fractions were obtained.
Western blots
Fractions from the sucrose gradient were subjected to SDS-PAGE by the Laemmli method and transferred to Hybond nitrocellulose (Amersham, Arlington Heights, IL) utilizing a BioRad transblot apparatus (25) . The blots were probed with antibody to mobilferrin and developed by an enhanced chemiluminescence method (Amersham).
Gel filtration
An Ultrogel AcA44 column (IBF Biotechnics, Columbia, MD) column (1.5 ϫ 50 cm) was equilibrated with HNa. Selected samples from the sucrose gradient were combined with an equal volume of 2 M NaC1 and incubated at 37 Њ C for 10 min. The sample was applied to the column and fractions of 1 ml were obtained and the radioactivity determined. The column was calibrated with authentic samples of protein of known molecular mass. The fractions containing radioactivity corresponding to the elution volume of mobilferrin were pooled and mixed with 1:300 dilutions of antibody to mobilferrin and incubated at 4 Њ C for 24 h. 25 l of Sepharose-protein G (Sigma Chemical Co.) was added, and incubated at 4 Њ C overnight. It was collected by centrifugation and washed three times with HNa. Radioactivity on the beads was then quantified in a gamma counter.
Pulse chase
For each determination, 2 ml of K562 cells (1.9 ϫ 10 6 ) was incubated with 20 l of 59 Fe-radiolabeled diferric human transferrin (1 mg/ml). After a 10-min incubation at 37 Њ C unlabeled differic human transferrin (200 l of 10 mg/ml) was added and the incubation continued for various times at 37 Њ C in HSG. After incubation the cells were rapidly chilled, collected by centrifugation (2,000 g for 10 min), washed twice in HSG, and lysed by freezing and thawing in 1 ml of HNa buffer followed by sonification (25 W, 1 min). After complete lysis was confirmed by microscopy, the cytosolic fraction was recovered by centrifugation in a microcentrifuge for 15 min. Antibody against either mobilferrin or hemoglobin (20 l) was added to 320 l of the cytosol and incubated at 4 Њ C for 4 h. An appropriate secondary antibody (goat anti-rabbit, Sigma Chemical Co.) was added and allowed to form a precipitate overnight. The immunoprecipitate was recovered by centrifugation, washed twice in HSG, and the radioactivity in the precipitate determined for each interval.
Antibody against mobilferrin was obtained as a polyclonal anticalreticulin antibody (Affinity Bioreagants Inc., Golden, CO). Mobilferrin is a homologue of calreticulin and antibodies were shown to be cross-reactive (26) . This antibody was chosen because it retains its immunoreactivity after heating at 100 Њ C better than our available anti- 
Results
Transferrin conveys iron to mobilferrin. K562 cells were incubated with 59 Fe radiolabeled diferric transferrin for 10 min at 37 Њ C. The label was then chased with 25-fold excess of unlabeled diferric transferrin for the indicated times (Fig. 1) . Cells were chilled, collected, lysed, and the supernatants were reacted with antibody to mobilferrin and hemoglobin. Radiolabeled iron from transferrin was taken into cells. Iron was initially released from transferrin, the label was chased into hemoglobin. This established a pathway of iron transit from transferrin to mobilferrin to hemoglobin. When a similar experiment was performed with NH 4 C1 (Fig. 1 B ) the transfer of iron was inhibited. The NH 4 C1 inhibits the acidification of the endosome (22) . Since NH 4 C1 has a specific effect on the endosome and inhibited the labeling of both mobilferrin and hemoglobin, the endosomal transferrin must have initiated the pathway. On the other hand, when iron was transported from iron citrate by the MIP pathway, the endosome was not involved and the addition of NH 4 C1 had no effect (Fig. 1, C and D ) .
Mobilferrin is located with the clathrin-coated vesicle. The pulse chase experiments described above implicated mobilferrin in the internalization of iron from vesicles containing radioiron transferrin. Mobilferrin was initially isolated from the cytoplasmic fraction of intestinal cells (8) and was found homologous to calreticulin a protein that is usually membrane associated (26, 27) . Western blot analysis of sucrose gradients separating membrane fractions of K562 cells demonstrated the presence of mobilferrin/calreticulin both in the cytoplasm and associated with clathrin-coated vesicles (Fig. 2) . Clathrincoated vesicles are known to be associated with a large variety of proteins in addition to transferrin (28) . Thus some mobilferrin was present in fractions containing the clathrin immunoreactive fractions which are associated with the transferrin containing vesicle.
Mobilferrin accepts iron from transferrin in the vesicle. K562 cells were incubated with 59 Fe labeled diferric transferrin and 125 I-labeled diferric transferrin in the presence of 15 mM NH 4 C1. The NH 4 C1 was used to block release of iron from transferrin in vesicles (22) . After lysis of the cells, the vesicle portion was separated from the cytoplasm by 60-20% sucrose gradient (Fig. 3 A ) . The clathrin containing vesicles were identified by Western blot demonstrating the presence of clathrin (fractions [9] [10] [11] [12] [13] [14] . This peak contained both 59 Fe and 125 I demonstrating the coincident presence of transferrin protein and iron in these vesicles. A second peak (fractions 20-23) contained 125 I (and therefore the protein portion of transferrin) but proportionately much less 59 Fe, suggesting that the transferrin had released the majority of the iron originally bound. The cytoplasm (fractions Ͼ 24) had insignificant amounts of radioiron or transferrin.
The vesicles containing iron and transferrin (fractions 9-11) were incubated with 1 M NaC1 to dissociate mobilferrin from the vesicles and then were placed on an Ultrogel AcA44 column. The elution of radioactive iron was determined (Fig. 3 B ) . Iron was found at the void volume (labeled vesicles ). Small quantities of radioiron were also found at an elution volume corresponding to transferrin. In addition, radiolabeled iron was detected at a hydrodynamic volume corresponding to mobilferrin. Incubation of the vesicles with either low salt concentrations or with 4 M urea failed to release a fraction corresponding to mobilferrin, suggesting that there was an electrostatic association between the vesicle and mobilferrin. Immunoprecipitation of the mobilferrin peak with anti-mobilferrin (data not shown) indicated that radioactive iron was present in immunoreactive mobilferrin.
Utilization of transferrin iron. K562 cells were incubated under identical conditions but in the absence of NH 4 C1 and cell homogenates were separated on sucrose gradients. With progressive times of incubation, iron continued to increase in the high density fraction (Fig. 4 A ) . Accumulation of iron in this fraction (fractions 2-8) was markedly inhibited (threefold) by the specific potent inhibitor of heme synthesis succinylacetone without affecting cell viability (Trypan blue) (29) . This dense fraction contains hemoglobin and/or other heme-containing proteins in various synthetic stages. In the cytoplasmic portion of the gradient (fractions 23-28) material containing 59 Fe was detected after 10 min incubation. When this material was subjected to chromatography on an Ultrogel AcA44 column (Fig. 4 B ) a portion of the radioactivity was found with an elution volume coincident with mobilferrin. This implied that cytoplasmic mobilferrin was labeled from transferrin iron originally derived from the vesicles; this was consistent with the pulse-chase experiments described earlier. The sucrose gradients did not demonstrate whether mobilferrin in the cytoplasm was labeled before heme synthesis or subsequently. However, the role of cytoplasmic mobilferrin as a precursor to hemoglobin was apparent in the pulse-chase studies.
Discussion
K562 erythroleukemia cells are capable of acquiring iron from tissue culture media utilizing either the transferrin-transferrin Figure 4 . Iron is released from transferrin to bind mobilferrin and form end products. (A) A sucrose gradient was used to separate organelles from K562 cells in the absence of NH 4 C1. Incubation, lysis and centrifugation were performed as described in Fig. 3 . The ordinate shows cpm of 59 Fe present in the individual fractions after incubation of the K562 cells at 37 Њ C for 0 min ( ᭡ ), 1 minute ( ) and 10 min ( ᭹ ). ( B ) The cytoplasmic ( A , fractions, 23-28 after 10 min incubation) portion of the gradient was pooled, adjusted to 1M NaC1 and chromatographed on an Ultrogel AcA44 column as described in Fig. 3 . The cpm of 59 Fe was determined for each fraction. Authentic samples of transferrin (Tf) and mobilferrin (Mb) eluted at the indicated fractions, and the void volume of the column was at fraction 27. The peak observed at fraction 53 was coincident with the molecular mass of mobilferrin as exhibited on this column.
receptor pathway or the mobilferrin-integrin pathway (1, 21) . Iron acquired via both pathways becomes available to the cell for the production of end products such as hemoglobin and ferritin (21) . Previous studies suggested that some iron presented to these cells bound to transferrin subsequently was found labeled to mobilferrin isolated from the cell cytosol. This suggested an interrelationship between the transferrintransferrin receptor pathway and the mobilferrin-integrin pathway in which mobilferrin served as a common constituent of both pathways (21) . Possibly this occurs because of the close association of mobilferrin and flavin monooxygenase (30). The latter complex can serve as a NADPH dependent ferrireductase and iron must be converted to the ferrous state to be utilized for production of heme proteins.
In the current studies radiolabeled iron from transferrin was transferred to mobilferrin in K562 cells. Pulse-chase experiments showed that transferrin iron subsequently bound mobilferrin and then, in turn, hemoglobin. This processing of iron by the cell was blocked by NH 4 Cl which prevented acidification of the endosome (24) and delays the release of iron from transferrin internalized in the endosome. While NH 4 Cl dramatically suppressed the utilization of transferrin iron for labeling of mobilferrin, NH 4 Cl had no significant effect upon the labeling of mobilferrin when cells were incubated in radiolabeled ferric citrate. This provided assurance that radioiron was not released from transferrin before passage into the cell within the endosome. Although precise quantification can not be obtained by methods used in this study, the pulse chase experimental results suggested that a substantive portion of the iron from transferrin passed through mobilferrin before being incorporated into hemoglobin (Fig. 1) . Since mobilferrin was shown by Western blots to colocalize with the endosome, it was likely that mobilferrin docked on the endosome to bind iron released from intravesicular transferrin. Subsequently the iron bound to mobilferrin became available for use by the cell with mobilferrin serving as a shuttle protein for delivery of iron in the appropriate redox state.
Due to the rapid transit, release, and metabolism of transferrin iron, these data do not exclude other, as yet, uncharacterized intermediates or an additional pathway (31) . The exact mechanism by which free iron crosses the membrane from the endosome to the cytoplasm is not clear and may involve either H ϩ ATPase (32) or a mechanism similar to the pathway described in intestinal mucosa (7) . In broadest outline, a pathway for the transport and utilization of iron is beginning to emerge (Fig. 5) . A multiplicity of other factors needed to control the movement and redox of iron remain to be defined. Figure 5 . Schematic diagram of iron transport in K562 cells. The classic transferrin (Tf) mediated iron uptake occurs by means of a specific transferrin receptor (R). The complex of protein and receptor are internalized in clathrin coated pits and fused with the endosome, which during acidification releases the iron. The non-transferrin pathway utilizes inorganic iron in the form of chelates, the most common of which is citrate. The iron transits the membrane in association with a cell surface integrin. The two pathways converge as mobilferrin accepts the iron. The iron is reduced, possibly by the mobilferrin containing complex paraferritin in order to be utilized by the mitochondrial protein ferrochelatase which combines the iron and porphyrin for heme synthesis. There are undoubtably other proteins and factors involved in this pathway which remain to be described.
